Activation, immune polarization, and graft-versus-leukemia activity of donor T cells are regulated by specific subsets of donor bone marrow antigen-presenting cells in allogeneic hemopoietic stem cell transplantation

Journal of Immunology

Volumn 183, Issue 12, 2009, Pages 7799-7809

  Li, Jian Ming ^a   Southerland, Lauren T ^b   Lu, Ying ^a   Darlak, Kataryna A ^a   Giver, Cynthia R ^a   McMillin, Douglas W ^c   Harris, Wayne A C ^a   Jaye, David L ^a   Waller, Edmund K ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATAXIN 1; B7 ANTIGEN; CD11B ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON RECEPTOR 1; GLYCOPROTEIN P 15095; INTERLEUKIN 2; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 LIGAND 2; STEM CELL FACTOR RECEPTOR; ALLOANTIGEN;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; BONE MARROW; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL ACTIVITY; CELL PROLIFERATION; CHIMERA; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GRAFT VERSUS LEUKEMIA EFFECT; HEMATOPOIETIC STEM CELL; MOUSE; NONHUMAN; PLASMACYTOID DENDRITIC CELL; POLARIZATION; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL; TH2 CELL; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; BONE MARROW CELL; C3H MOUSE; C57BL MOUSE; CELL POLARITY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; METHODOLOGY; T LYMPHOCYTE SUBPOPULATION; TRANSGENIC MOUSE; TRANSPLANTATION; TUMOR CELL LINE;

ANIMALS; ANTIGEN-PRESENTING CELLS; BONE MARROW CELLS; CELL LINE, TUMOR; CELL POLARITY; GRAFT ENHANCEMENT, IMMUNOLOGIC; GRAFT VS LEUKEMIA EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; ISOANTIGENS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, TRANSGENIC; T-LYMPHOCYTE SUBSETS;

EID: 76249124161     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0900155     Document Type: Article

References (63)

1. Martin-Fontecha, A., S. Sebastiani, U. E. Hopken, M. Uguccioni, M. Lipp, A. Lanzavecchia, and F. Sallusto. 2003. Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J. Exp. Med. 198: 615-621.
2. Bogunovic, M., F. Ginhoux, A. Wagers, M. Loubeau, L. M. Isola, L. Lubrano, V. Najfeld, R. G. Phelps, C. Grosskreutz, E. Scigliano, P. S. Frenette, and M. Merad. 2006. Identification of a radio-resistant and cycling dermal dendritic cell population in mice and men. J. Exp. Med. 203: 2627-2638.
3. Durakovic, N., K. B. Bezak, M. Skarica, V. Radojcic, E. J. Fuchs, G. F. Murphy, and L. Luznik. 2006. Host-derived Langerhans cells persist after MHC-matched allografting independent of donor T cells and critically influence the alloresponses mediated by donor lymphocyte infusions. J. Immunol. 177: 4414-4425. (Pubitemid 44469770)
4. Shlomchik, W. D., M. S. Couzens, C. B. Tang, J. McNiff, M. E. Robert, J. Liu, M. J. Shlomchik, and S. G. Emerson. 1999. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 285: 412-415. (Pubitemid 29343964)
5. Duffner, U. A., Y. Maeda, K. R. Cooke, P. Reddy, R. Ordemann, C. Liu, J. L. Ferrara, and T. Teshima. 2004. Host dendritic cells alone are sufficient to initiate acute graft-versus-host disease. J. Immunol. 172: 7393-7398. (Pubitemid 38747600)
6. Merad, M., P. Hoffmann, E. Ranheim, S. Slaymaker, M. G. Manz, S. A. Lira, I. Charo, D. N. Cook, I. L. Weissman, S. Strober, and E. G. Engleman. 2004. Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease. Nat. Med. 10: 510-517.
7. Chakraverty, R., and M. Sykes. 2007. The role of antigen-presenting cells in triggering graft-versus-host disease and graft-versus-leukemia. Blood 110: 9-17. (Pubitemid 47026813)
8. Anderson, B. E., J. M. McNiff, D. Jain, B. R. Blazar, W. D. Shlomchik, and M. J. Shlomchik. 2005. Distinct roles for donor- and host-derived antigen-presenting cells and costimulatory molecules in murine chronic graft-versus-host disease: requirements depend on target organ. Blood 105: 2227-2234.
9. Waller, E. K., H. Rosenthal, T. W. Jones, J. Peel, S. Lonial, A. Langston, I. Redei, I. Jurickova, and M. W. Boyer. 2001. Larger numbers of CD4bright dendritic cells in donor bone marrow are associated with increased relapse after allogeneic bone marrow transplantation. Blood 97: 2948-2956.
10. Dean, R., P. Masci, B. Pohlman, S. Andresen, S. Serafino, R. Sobecks, E. Kuczkowski, J. Curtis, J. Maciejewski, L. Rybicki, et al. 2005. Dendritic cells in autologous hematopoietic stem cell transplantation for diffuse large B-cell lymphoma: graft content and post transplant recovery predict survival. Bone Marrow Transplant. 36: 1049-1052.
11. Reddy, V., J. A. Iturraspe, A. C. Tzolas, H. U. Meier-Kriesche, J. Schold, and J. R. Wingard. 2004. Low dendritic cell count after allogeneic hematopoietic stem cell transplantation predicts relapse, death, and acute graft-versus-host disease. Blood 103: 4330-4335.
12. Liu, Y. J. 2001. Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell 106: 259-262.
13. Hume, D. A. 2008. Macrophages as APC and the dendritic cell myth. J. Immunol. 181: 5829-5835.
14. Shortman, K., and Y. J. Liu. 2002. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2: 151-161.
15. Liu, K., G. D. Victora, T. A. Schwickert, P. Guermonprez, M. M. Meredith, K. Yao, F. F. Chu, G. J. Randolph, A. Y. Rudensky, and M. Nussenzweig. 2009. In vivo analysis of dendritic cell development and homeostasis. Science 324: 392-397.
16. Li, J. M., and E. K. Waller. 2004. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation. Biol. Blood Marrow Transplant. 10: 540-551.
17. Matte, C. C., J. Liu, J. Cormier, B. E. Anderson, I. Athanasiadis, D. Jain, J. McNiff, and W. D. Shlomchik. 2004. Donor APCs are required for maximal GVHD but not for GVL. Nat. Med. 10: 987-992.
18. + dendritic cells only after microbial stimulus. J. Exp. Med. 196: 1307-1319.
19. van den Berg, T. K., and G. Kraal. 2005. A function for the macrophage F4/80 molecule in tolerance induction. Trends Immunol. 26: 506-509.
20. + T cells. Blood 96: 3838-3846.
21. Colonna, M., G. Trinchieri, and Y. J. Liu. 2004. Plasmacytoid dendritic cells in immunity. Nat. Immunol. 5: 1219-1226.
22. Gilliet, M., A. Boonstra, C. Paturel, S. Antonenko, X. L. Xu, G. Trinchieri, A. O'Garra, and Y. J. Liu. 2002. The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 195: 953-958.
23. Pulendran, B., J. L. Smith, G. Caspary, K. Brasel, D. Pettit, E. Maraskovsky, and C. R. Maliszewski. 1999. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc. Natl. Acad. Sci. USA 96: 1036-1041.
24. + DC1 precursors. Blood 101: 1453-1459.
25. Koyama, M., D. Hashimoto, K. Aoyama, K. Matsuoka, K. Karube, H. Niiro, M. Harada, M. Tanimoto, K. Akashi, and T. Teshima. 2009. Plasmacytoid dendritic cells prime alloreactive T cells to mediate graft-versus-host disease as antigen- presenting cells. Blood 113: 2088-2095.
26. + subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J. Exp. Med. 189: 587-592.
27. Korngold, R., C. Leighton, and T. Manser. 1994. Graft-versus-myeloid leukemia responses following syngeneic and allogeneic bone marrow transplantation. Transplantation 58: 278-287.
28. Gillis, S., and S. B. Mizel. 1981. T-cell lymphoma model for the analysis of interleukin 1-mediated T-cell activation. Proc. Natl. Acad. Sci. USA 78: 1133-1137.
29. Waller, E. K., A. M. Ship, S. Mittelstaedt, T. W. Murray, R. Carter, I. Kakhniashvili, S. Lonial, J. T. Holden, and M. W. Boyer. 1999. Irradiated donor leukocytes promote engraftment of allogeneic bone marrow in major histocompatibility complex mismatched recipients without causing graft-versus-host disease. Blood 94: 3222-3233.
30. Giver, C. R., R. O. Montes, S. Mittelstaedt, J. M. Li, D. L. Jaye, S. Lonial, M. W. Boyer, and E. K. Waller. 2003. Ex vivo fludarabine exposure inhibits graft-versus-host activity of allogeneic T cells while preserving graft-versus-leukemia effects. Biol. Blood Marrow Transplant. 9: 616-632.
31. Cooke, K. R., L. Kobzik, T. R. Martin, J. Brewer, J. Delmonte, Jr., J. M. Crawford, and J. L. Ferrara. 1996. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation. I. The roles of minor H antigens and endotoxin. Blood 88: 3230-3239.
32. Li, J. M., J. Gorechlad, C. P. Larsen, and E. K. Waller. 2006. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation. Biol. Blood Marrow Transplant. 12: 1239-1249.
33. Fugier-Vivier, I. J., F. Rezzoug, Y. Huang, A. J. Graul-Layman, C. L. Schanie, H. Xu, P. M. Chilton, and S. T. Ildstad. 2005. Plasmacytoid precursor dendritic cells facilitate allogeneic hematopoietic stem cell engraftment. J. Exp. Med. 201: 373-383.
34. Vremec, D., and K. Shortman. 1997. Dendritic cell subtypes in mouse lymphoid organs: cross-correlation of surface markers, changes with incubation, and differences among thymus, spleen, and lymph nodes. J. Immunol. 159: 565-573.
35. Liu, K., C. Waskow, X. Liu, K. Yao, J. Hoh, and M. Nussenzweig. 2007. Origin of dendritic cells in peripheral lymphoid organs of mice. Nat. Immunol. 8: 578-583.
36. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony- stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J. Exp. Med. 179: 1109-1118.
37. McKee, A. S., F. Dzierszinski, M. Boes, D. S. Roos, and E. J. Pearce. 2004. Functional inactivation of immature dendritic cells by the intracellular parasite Toxoplasma gondii. J. Immunol. 173: 2632-2640. (Pubitemid 39063123)
38. Banovic, T., K. P. MacDonald, E. S. Morris, V. Rowe, R. Kuns, A. Don, J. Kelly, S. Ledbetter, A. D. Clouston, and G. R. Hill. 2005. TGF-β in allogeneic stem cell transplantation: friend or foe? Blood 106: 2206-2214.
39. MacDonald, K. P., V. Rowe, C. Filippich, R. Thomas, A. D. Clouston, J. K. Welply, D. N. Hart, J. L. Ferrara, and G. R. Hill. 2003. Donor pretreatment with progenipoietin-1 is superior to granulocyte colony-stimulating factor in preventing graft-versus-host disease after allogeneic stem cell transplantation. Blood 101: 2033-2042.
40. Hadeiba, H., T. Sato, A. Habtezion, C. Oderup, J. Pan, and E. C. Butcher. 2008. CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease. Nat. Immunol. 9: 1253-1260.
41. Gabrilovich, D. I., S. Nadaf, J. Corak, J. A. Berzofsky, and D. P. Carbone. 1996. Dendritic cells in antitumor immune responses. II. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice, are effective antigen carriers in the therapy of established tumors. Cell. Immunol. 170: 111-119.
42. Waller, E. K., H. Rosenthal, and L. Sagar. 2002. DC2 effect on survival following allogeneic bone marrow transplantation. Oncology 16: 19-26.
43. Li, J. M., and E. K. Waller. 2007. The yin and yang of adaptive immunity in allogeneic hematopoietic cell transplantation: donor antigen-presenting cells can either augment or inhibit donor T cell alloreactivity. Adv. Exp. Med. Biol. 590: 69-87.
44. Kohara, H., Y. Omatsu, T. Sugiyama, M. Noda, N. Fujii, and T. Nagasawa. 2007. Development of plasmacytoid dendritic cells in bone marrow stromal cell niches requires CXCL12-CXCR4 chemokine signaling. Blood 110: 4153-4160. (Pubitemid 351377776)
45. + dendritic cells endowed with type 1 interferon production capacity and tolerogenic potential. Blood 100: 383-390.
46. Lonial, S., C. Torre, E. David, W. Harris, M. Arellano, and E. K. Waller. 2008. Regulation of alloimmune responses by dendritic cell subsets. Exp. Hematol. 36: 1309-1317.
47. Liu, Y. J. 2005. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu. Rev. Immunol. 23: 275-306.
48. Haase, C., M. Ejrnaes, A. E. Juedes, T. Wolfe, H. Markholst, and M. G. von Herrath. 2005. Immunomodulatory dendritic cells require autologous serum to circumvent nonspecific immunosuppressive activity in vivo. Blood 106: 4225-4233. (Pubitemid 41775930)
49. Munn, D. H., M. D. Sharma, D. Hou, B. Baban, J. R. Lee, S. J. Antonia, J. L. Messina, P. Chandler, P. A. Koni, and A. L. Mellor. 2004. Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. J. Clin. Invest. 114: 280-290.
50. Naik, S. H., D. Metcalf, A. van Nieuwenhuijze, I. Wicks, L. Wu, M. O'Keeffe, and K. Shortman. 2006. Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes. Nat. Immunol. 7: 663-671.
51. Banovic, T., K. A. Markey, R. D. Kuns, S. D. Olver, N. C. Raffelt, A. L. Don, M. A. Degli-Esposti, C. R. Engwerda, K. P. MacDonald, and G. R. Hill. 2009. Graft-versus-host disease prevents the maturation of plasmacytoid dendritic cells. J. Immunol. 182: 912-920.
52. Schnorrer, P., G. M. Behrens, N. S. Wilson, J. L. Pooley, C. M. Smith, D. El-Sukkari, G. Davey, F. Kupresanin, M. Li, E. Maraskovsky, et al. 2006. The dominant role of CD8+ dendritic cells in cross-presentation is not dictated by antigen capture. Proc. Natl. Acad. Sci. USA 103: 10729-10734.
53. Yang, Y. G., J. Qi, M. G. Wang, and M. Sykes. 2002. Donor-derived interferon γ separates graft-versus-leukemia effects and graft-versus-host disease induced by donor CD8 T cells. Blood 99: 4207-4215.
54. Reddy, P., Y. Maeda, C. Liu, O. I. Krijanovski, R. Korngold, and J. L. Ferrara. 2005. A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses. Nat. Med. 11: 1244-1249.
55. Asavaroengchai, W., H. Wang, S. Wang, L. Wang, R. Bronson, M. Sykes, and Y. G. Yang. 2007. An essential role for IFN-γ in regulation of alloreactive CD8 T cells following allogeneic hematopoietic cell transplantation. Biol. Blood Marrow Transplant. 13: 46-55.
56. Markey, K. A., K. P. MacDonald, and G. R. Hill. 2009. Recipient plasmacytoid DCs are not required to prime allogeneic T-cell responses after BMT. Blood 113: 6038-6039.
57. Markey, K. A., T. Banovic, R. D. Kuns, S. D. Olver, A. L. Don, N. C. Raffelt, Y. A. Wilson, L. J. Raggatt, A. R. Pettit, J. S. Bromberg, G. R. Hill, and K. P. MacDonald. 2009. Conventional dendritic cells are the critical donor APC presenting alloantigen after experimental bone marrow transplantation. Blood 113: 5644-5649.
58. Colson, Y. L., K. Christopher, J. Glickman, K. N. Taylor, R. Wright, and D. L. Perkins. 2004. Absence of clinical GVHD and the in vivo induction of regulatory T cells after transplantation of facilitating cells. Blood 104: 3829-3835.
59. Blank, C., I. Brown, A. C. Peterson, M. Spiotto, Y. Iwai, T. Honjo, and T. F. Gajewski. 2004. PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells. Cancer Res. 64: 1140-1145. (Pubitemid 38176921)
60. Mielcarek, M., L. Graf, G. Johnson, and B. Torok-Storb. 1998. Production of interleukin-10 by granulocyte colony-stimulating factor-mobilized blood products: a mechanism for monocyte-mediated suppression of T-cell proliferation. Blood 92: 215-222. (Pubitemid 28303195)
61. Pelayo, R., J. Hirose, J. Huang, K. P. Garrett, A. Delogu, M. Busslinger, and P. W. Kincade. 2005. Derivation of two categories of plasmacytoid dendritic cells in murine bone marrow. Blood 105: 4407-4415. (Pubitemid 40720788)
62. Kamogawa-Schifter, Y., J. Ohkawa, S. Namiki, N. Arai, K. Arai, and Y. Liu. 2005. Ly49Q defines 2 pDC subsets in mice. Blood 105: 2787-2792. (Pubitemid 40446271)
63. Boonstra, A., C. Asselin-Paturel, M. Gilliet, C. Crain, G. Trinchieri, Y. J. Liu, and A. O'Garra. 2003. Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: dependency on antigen dose and differential toll-like receptor ligation. J. Exp. Med. 197: 101-109.